The COVID-19 pandemic in China: from dynamic zero-COVID to current policy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00059-023-05183-5.pdf
Reference10 articles.
1. Zheng JX, Lv S, Tian LG et al (2022) The rapid and efficient strategy for SARS-CoV‑2 Omicron transmission control: analysis of outbreaks at the city level. Infect Dis Poverty 11(1):114
2. Cai J, Deng X, Yang J et al (2022) Modeling transmission of SARS-CoV‑2 Omicron in China. Nat Med 28(7):1468–1475
3. Iuliano AD, Brunkard JM, Boehmer TK et al (2022) Trends in disease severity and health care utilization during the early omicron variant period compared with previous SARS-coV‑2 high transmission periods—United States, december 2020–january 2022. Mmwr Morb Mortal Wkly Rep 71(4):146–152
4. Nyberg T, Ferguson NM, Nash SG et al (2022) Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV‑2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet 399(10332):1303–1312
5. Altmann DM, Boyton RJ (2022) COVID-19 vaccination: The road ahead. Science 375(6585):1127–1132
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Predicting the transmission dynamics of novel coronavirus infection in Shanxi province after the implementation of the “Class B infectious disease Class B management” policy;Frontiers in Public Health;2023-12-22
2. Willingness to receive and recommend hypothetical mpox vaccination and associated factors in Chinese adults: a community-based survey in Shenzhen, China;Public Health;2023-12
3. The effect of the earliest COVID-19 outbreak on survival in uninfected advanced NSCLC patients receiving chemotherapy in Jiangsu Province, China: A retrospective cohort study;Medicine;2023-09-29
4. COVID-19 related network public opinion on the Chinese microblogging platform Weibo: A bibliometric assessment using data from the Web of Science (Preprint);2023-08-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3